FAP and neoplasm: Notably, compared to the tumor with PANC-1 injection alone, the tumor with the co-injection of PANC-1 and CAFs had a stronger positive expression of FAP and α-SMA (Additional file 1: Fig. S4), indicating that it was CAFs that provided the target for 131I-FAP-2286.